Patients with end-stage renal disease (ESRD) are at an increased risk of developing sarcopenia, which can lead to various adverse health outcomes. Although the diagnosis of sarcopenia is essential for clinical management, it is not feasible in routine clinical practice for populations undergoing haemodialysis because it is time-consuming and resources are limited. Serum creatinine levels in patients with ESRD have been gaining attention as a screening parameter for sarcopenia because serum creatinine is a routinely measured byproduct of skeletal muscle metabolism. This study aimed to evaluate the discriminative ability of the creatinine-derived index for sarcopenia in patients undergoing haemodialysis.

中文翻译：

---

血液透析患者肌肉减少症的简化判别参数

终末期肾病 (ESRD) 患者患肌肉减少症的风险增加，这可能导致各种不良健康结果。尽管肌肉减少症的诊断对于临床管理至关重要，但由于耗时且资源有限，因此在接受血液透析的人群的常规临床实践中并不可行。ESRD 患者的血清肌酐水平作为肌肉减少症的筛查参数一直受到关注，因为血清肌酐是骨骼肌代谢的常规测量副产物。本研究旨在评估肌酐衍生指数对血液透析患者肌肉减少症的鉴别能力。